UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057263 |
|---|---|
| Receipt number | R000063951 |
| Scientific Title | Effect of Different Hemofilters Used in Continuous Renal Replacement Therapy on the Prognosis of Septic Acute Kidney Injury |
| Date of disclosure of the study information | 2025/03/12 |
| Last modified on | 2025/09/12 11:19:44 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of Different Hemofilters Used in Continuous Renal Replacement Therapy on the Prognosis of Septic Acute Kidney Injury
Acronym
Effect of Different Hemofilters Used in Continuous Renal Replacement Therapy on the Prognosis of Septic Acute Kidney Injury
Scientific Title
Effect of Different Hemofilters Used in Continuous Renal Replacement Therapy on the Prognosis of Septic Acute Kidney Injury
Scientific Title:Acronym
Effect of Different Hemofilters Used in Continuous Renal Replacement Therapy on the Prognosis of Septic Acute Kidney Injury
Region
| Japan |
Condition
Condition
sepsis
Classification by specialty
| Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Comparative Study of Cytokine Adsorption Clearance and Mortality Rates with Hemofilters Used in Continuous Renal Replacement Therapy in the ICU
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Phase I
Assessment
Primary outcomes
Cytokine Adsorption Clearance
Key secondary outcomes
1.28days survival rate
2.Changes in Various Measured Parameters Before and After the Hemofilter
3.Correlation Between Changes in Measured Parameters and Severity Scores
4.Trend of SOFA Scores Over 7 Days from the Start of CKRT
5.Trend of Catecholamine Index Over 7 Days from the Start of CKRT
6.Trend of P/F Ratio Over 7 Days from the Start of CKRT
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
Blood purification using AN69ST hemofilter
Interventions/Control_2
Blood purification using PS hemofilter
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1.>=20 years of old
2.sepsis
3.Patients for whom the attending physician determined that continuous renal replacement therapy (CRRT) was necessary
Key exclusion criteria
1.Patients from whom consent was not obtained
2.Patients post-cardiopulmonary resuscitation
3.Pregnant patients
4.Individuals deemed unsuitable for participation in the study by the researchers
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Yoshihiko |
| Middle name | |
| Last name | Nakamura |
Organization
Faculty of Medicine,Fukuoka University
Division name
Department of Emergency and Critical Care Medicine
Zip code
8140180
Address
7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
TEL
092-801-1011
nakamura58@fukuoka-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoshihiko |
| Middle name | |
| Last name | Nakamura |
Organization
Faculty of Medicine,Fukuoka University
Division name
Department of Emergency and Critical Care Medicine
Zip code
8140180
Address
7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
TEL
092-801-1011
Homepage URL
pdmxy827@yahoo.co.jp
Sponsor or person
Institute
Fukuoka University
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Fukuoka University Hospital Clinical Resarch Assist Center
Address
7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
Tel
092-801-1011
rinshou@adm.fukuoka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
福岡大学病院 救命救急センター
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 03 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 03 | Month | 10 | Day |
Date of IRB
| 2025 | Year | 03 | Month | 10 | Day |
Anticipated trial start date
| 2025 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 03 | Month | 12 | Day |
Last modified on
| 2025 | Year | 09 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063951
